Introduction
SOM-mediated inflammation-suppressive effects can be subdivided into two classes of action. The first one consists of the effects of SOM on inflammatory cells, either directly by targeting these cells or indirectly by modulating cells capable of synthesizing and releasing pro-inflammatory mediators. The best documented effects in this category include the somatostatinergic inhibition of lymphoid cell proliferation, cytokine and immunoglobulin production and the release of interferon-␥ and of interleukins
. The [8, 9] . This neuronally released SOM exerts both a local, inhibitory effect on the release of the pro-inflammatory peptides substance P and CGRP, and a short-lasting systemic anti-inflammatory action via the systemic circulation [10] . Moreover, [11] [12] [13] [14] .
second group of SOM-mediated anti-inflammatory actions is less well understood and includes suppression of the release of pro-inflammatory peptides from sensory nerve endings. During inflammation, pro-inflammatory mediators, mainly tachykinins (substance P and neurokinin A) and calcitonin generelated peptide (CGRP), are released from capsaicin-sensitive sensory nerve endings, initiating an inflammatory cascade. In several non-intestinal tissues, the effects of these peptides are counteracted by SOM, released from nerve terminals of the same or distinct populations of primary afferent neurons

this locally released, neuronally derived SOM acts as a potent analgesic by inhibiting the excitability of peripheral nociceptors, including transient receptor potential vanilloid type 1 (TRPV1)
In contrast to the direct effects of SOM on inflammatory cells, which probably involve all SSTR subtypes, the neurogenic inhibitory and analgesic effects of SOM seem to be primarily mediated by SSTR4 and, to a lesser extent, SSTR1. Recent pharmacological studies demonstrated the potency of SSTR4-selective agonists to reduce neurogenic and non-neurogenic inflammatory reactions in various animal models, whereas the mainly SSTR2-preferring SOM analogue octreotide had no effect [15] [16] [17] . In line with these results, we were recently able to demonstrate by means of immunohistochemistry the expression of SSTR4 in extrinsic afferent nerve fibres supplying the murine small intestine [1] .
However, the specific functional role of this receptor in GI pathology remains to be investigated. The recent availability of SSTR4 -/-mice opens up a unique opportunity to investigate the unexplored role of this receptor in GI activity, both in normal and in inflamed conditions. We therefore focussed on the expression of SOM, SSTRs and the pro-inflammatory neuropeptides substance P and CGRP in the small intestine of these knockout mice. Both the noninflamed and the inflamed murine ileum were used to study the postulated crucial role of a SSTR4-mediated pathway in the antiinflammatory actions of SOM in the GI tract (GIT). In line with our previous studies on the role of SOM and its receptors in GI pathophysiology, we used acutely Schistosoma (S.) mansoni-infected mice as a model for intestinal inflammation.
Moreover, as so far only the brain of SSTR4 knockout mice has been studied, information on the effects of SSTR4 on the morphological and functional characteristics of the murine small intestine is completely lacking [18, 19] 
Immunocytochemistry and quantitative analyses
All immunocytochemical incubations were performed as previously described [1, 2] . Primary antibodies were diluted in 0. stainings were performed [24] .
The specificity of all antibodies was verified on murine brain sections by pre-absorption with the appropriate antigens (1 g antigen per g antibody). Quantitative analyses were performed on whole-mount preparations and/or cryosections to determine (i) the density of SOM-and SSTR2A-immunoreactive (ir) neurons, (ii) the percentage of SSTR2A-ir neurons containing neuronal nitric oxide synthase (nNOS), (iii) the density of SOM-ir endocrine epithelial cells and (iv) the density of mucosal mast cells (MMC) in 8w p.i. conditions. Detailed procedures of
quantitative analyses were published previously [1, 2] . [26, 27] . In non-inflamed conditions, no morphological differences were observed in the structural organization of the WT and SSTR4 -/-ileum ( Fig. 1A and B) . In vivo motility studies revealed no significant 
Immunocytochemical analysis of nerve fibre densities in whole-mount preparations
RT-PCR
running within the outer muscle layers, at the base of the crypts of Lieberkühn and in the lamina propria. Whole-mount preparations revealed SOM expression in individual neurons and in a vast network of nerve fibres in both enteric plexuses of the SSTR4 -/-mice (Fig. 3A-C). The majority of these SOM-ir nerve fibres in whole-mount preparations did not co-express CGRP, indicative of their intrinsic origin [30]. A similar SOM distribution pattern was observed in cryosections of the 8w p.i. SSTR4 -/-ileum, with additional sprouting of SOM-ir nerve fibres in the lamina propria and in the granulomas. The density of SOM-ir myenteric neurons did not differ between WT and SSTR4 -/-mice in non-inflamed conditions. However, intestinal inflammation induced a significantly increased density of SOM-ir myenteric neurons in SSTR4 -/-mice, whereas the density in WT animals remained unaltered (Table 4). In contrast, the density of SOM-ir endocrine epithelial cells in the SSTR4 -/-ileum was dramatically reduced compared to WT animals, both in non-inflamed and in inflamed conditions (Table 5). However, intestinal inflammation decreased the density of SOM-ir endocrine cells in both WT and SSTR4
-/-mice.
In the non-inflamed SSTR4 -/-ileum, SSTR1 was detected in some epithelial cells at the base of the crypts of Lieberkühn and in nerve fibres at the base of the crypts, in both enteric plexuses (Fig. 3D) and in SOM-and CGRP-expressing nerve fibres in the lamina propria (Fig. 3E-H). All SSTR1-ir nerve fibres also expressed CGRP, demonstrating the exclusive presence of SSTR1 on extrinsic nerve fibres. The density of SSTR1-ir nerve fibres in the enteric plexuses was much higher in SSTR4 -/-than in WT animals (Table 6). The 8w p.i. SSTR4 -/-ileum was characterized by a similar SSTR1 distribution pattern, with additional expression of SSTR1 on almost all MMC and a strongly ramified network of SSTR1-ir nerve fibres in the lamina propria. As previously described in WT mice, the few MMC present in the non-inflamed SSTR4
-/-ileum did not express SSTR1 [1] .
SSTR2A IR was demonstrated in glial cells located in the lamina propria, at the base of the crypts of Lieberkühn and in the © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Table 4 Percentage of SOM-ir enteric neurons in whole-mount preparations of non-inflamed and 8w p.i. WT and SSTR4 -/-ileum. Results are expressed as the percentage of SOM-ir neurons in the enteric plexuses Ϯ standard deviation.
Table 5 Density of SOM-ir endocrine epithelial cells in non-inflamed and 8w p.i. WT and SSTR4 -/-ileum. Results are expressed as the number of SOM-ir endocrine epithelial cells per mm³ terminal ileum Ϯ standard deviation.
Non-inflamed 8w p.i. (Fig. 3J) , whereas only glial cells were labelled in the submucous plexus (Fig. 3K) (Fig. 3M) .
SSTR5 was expressed in endothelial cells of small-and medium-diameter blood vessels in SSTR4
-/-ileum, mainly in the submucosa and the lamina propria (Fig. 3N) 
